COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,286 Articles (22,759 medRxiv, 8,527 bioRxiv)

Most recent first Previous |  Page 591: Articles 5901-5910  | Next

Protection against reinfection with SARS-CoV-2 omicron BA.2.75* sublineage
Chemaitelly, H., Tang, P., Coyle, P., YASSINE, H. M., Al Khatib, H. A., Smatti, M. K., Hasan, M. R., Ayoub, H., Altarawneh, H. N., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H. J., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.10.29.22281606 — Posted: 2022-10-30
The relative contribution of COVID-19 infection versus COVID-19 related occupational stressors to insomnia in healthcare workers
Hendrickson, R. C., McCall, C. A., Rosser, A. F., Pagulayan, K. F., Chang, B. P., Sano, E. D., Thomas, R. G., Raskind, M. A.
10.1101/2022.10.27.22281582 — Posted: 2022-10-30
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study
Qian, G., Wang, X., Patel, N. J., Kawano, Y., Fu, X., Cook, C. E., Vanni, K. M. M., Kowalski, E. N., Banasiak, E. P., Bade, K. J., Srivatsan, S., Williams, Z. K., Todd, D. J., Weinblatt, M. E., Wallace, Z. S., Sparks, J. A.
10.1101/2022.10.27.22281629 — Posted: 2022-10-30
Results of safety monitoring of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in U.S. children aged 5-17 years
Hu, M., Wong, H. L., Feng, Y., Lloyd, P. C., Smith, E. R., Amend, K. L., Kline, A., Beachler, D. C., Gruber, J. F., Mitra, M., Seeger, J. D., Harris, C., Secora, A., Obidi, J., Wang, J., Song, J., McMahill-Walraven, C. N., Reich, C., McEvoy, R., Do, R., Chillarige, Y., Clifford, R., Cooper, D. D., Shoaibi, A., Forshee, R. A., Anderson, S. A.
10.1101/2022.10.28.22281532 — Posted: 2022-10-30
Forecasting Influenza-Like Illness (ILI) during the COVID-19 Pandemic
Turner, S. D., Hulme-Lowe, C., Nagraj, V. P.
10.1101/2022.10.27.22281617 — Posted: 2022-10-30
Understanding Inequalities in Mental Health by Family Structure during COVID-19 Lockdowns: Evidence from the UK Household Longitudinal Study
Green, M. J., Craig, P., Demou, E., Katikireddi, S. V., Leyland, A. H., Pearce, A.
10.1101/2022.10.27.22281616 — Posted: 2022-10-30
Preliminary report: Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, KD-414, in healthy adult participants: a non-randomized, open-label phase 2/3 clinical study in Japan
Kido, K., Ibaragi, K., Tanishima, M., Muramoto, Y., Nakayama, S., Ata, K., Hayashida, K., Nakamura, H., Shinmura, Y., Oda, Y., Endo, M., Sonoda, K., Sasagawa, Y., Iwama, Y., Ueda, K., Matsumoto, T.
10.1101/2022.10.27.22281603 — Posted: 2022-10-30
Machine learning models for predicting severe COVID-19 outcomes in hospitals
Wendland, P., Schmitt, V., Zimmermann, J., Haeger, L., Goepel, S., Schenkel-Haeger, C., Kschischo, M.
10.1101/2022.10.28.22281646 — Posted: 2022-10-30
Identifying trends in SARS-CoV-2 RNA in wastewater to infer changing COVID-19 incidence: Effect of sampling frequency
Chan, E. M. G., Kennedy, L., Wolfe, M., Boehm, A.
10.1101/2022.10.28.22281667 — Posted: 2022-10-30
Seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and adolescents in Montreal, Canada
Zinszer, K., Charland, K., Pierce, L., Saucier, A., McKinnon, B., Hamelin, M.-E., Cheriet, I., Barbosa Da Torre, M., Carbonneau, J., Nguyen, C. T., De Serres, G., Papenburg, J., Boivin, G., Quach, C.
10.1101/2022.10.28.22281660 — Posted: 2022-10-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).